Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 08 Nov 2023 for Evelo Biosciences, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
No signal scores available.
Mark Bodmer: trading record in brief
Mark Bodmer discloses dealings in Evelo Biosciences, Inc. to SEC (Form 4). Between 7 May 2023 and 7 November 2023, the trades on record add up to 6 filings.
No open-market purchase appears, only 2 sales. The totals exclude 2 filings filed without an amount. Other entries cover 4 option exercises.
On 8 November 2023 came the latest disclosure, an option exercise in Evelo Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Bodmer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6,625 sharesCommon StockSEC:0001694665-23-000179:0
12,500 sharesCommon StockSEC:0001694665-23-000169:0
6,625 sharesCommon StockSEC:0001694665-23-000136:0
22,571 shares@ €0.131727.7% of flowCommon StockSEC:0001694665-23-000080:0
68,014 shares@ €0.114172.3% of flowCommon StockSEC:0001694665-23-000053:0
132,500 sharesCommon StockSEC:0001694665-23-000042:0
6 of 6 declarations
